ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1418	National Cancer Institute	Html	en	Cancer-Related Post-traumatic Stress (PDQ®)–Patient Version	Shock, fear, helplessness, or horror can be felt by cancer patients at any time and lead to cancer-related post-traumatic stress. Learn about the causes and ways doctors can help manage these symptoms of distress in this expert-reviewed summary.	cancer treatment 0.338437 life-threatening stress 0.303648 natural disasters 0.295492 PDQ cancer information 0.517368 upsetting event 0.305231 clinical trial search 0.288109 certain triggers 0.298605 stressful events 0.297941 clinical trials 0.416557 cancer information summary 0.420357 clinical trial 0.342943 breast cancer prevention 0.304611 PDQ summaries 0.31577 patients 0.413744 cancer patients 0.39239 latest published information 0.297252 childhood cancer survivors 0.334732 cancer-related PTS 0.301933 NCI’s PDQ 0.315928 NCI PDQ cancer 0.384736 cancer survivors 0.382895 violent personal attack 0.28851 cancer-related post-traumatic stress 0.771546 Breast cancer survivors 0.324986	treatment 0.388516 post-traumatic stress disorder 0.44428 cancer prevention 0.308777 cancer experience 0.306174 anxiety disorders 0.288817 Cancer Information Service 0.325795 PDQ Supportive 0.310148 treatment clinical trials 0.303343 National Cancer Institute 0.448327 post-traumatic stress symptoms 0.498161 PDQ documents 0.307297 early symptoms 0.28734 Palliative Care Editorial 0.346292 new treatment 0.299459 possible cancer recurrence 0.324764 PDQ database 0.313308 Cancer Care page 0.31311 Care Editorial Board 0.347322 PDQ summary 0.393635 PTSD 0.349898 PTSD). 0.290236 cancer clinical trials 0.330243 cancer information summaries 0.334057 comprehensive cancer information 0.334182	CLICK HERE
1491	National Cancer Institute	Html	en	Laryngeal Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of laryngeal cancer.	Elective neck radiation 0.612858 locally advanced head 0.629434 radiation therapy-based treatment 0.65069 randomized controlled trials 0.580539 Engl J Med 0.592068 advanced laryngeal cancer 0.614525 radiation therapy. 0.583072 Laryngeal Cancer Study 0.614831 laryngeal cancer 0.719655 Int J Radiat 0.605237 randomized study 0.574463 Radiation Therapy Oncology 0.613999 neck cancer patients 0.594571 Radiat Oncol Biol 0.689017 induction chemotherapy group 0.591432 patients 0.718736 initial radiation 0.58218 standard treatment options 0.574341 lymph nodes 0.592104 early-stage larynx cancer 0.642059 radiation therapy 0.991511 beam radiation therapy 0.610314 et al. 0.672465 concomitant chemotherapy 0.657903	larynx cancer 0.643614 Affairs Laryngeal Cancer 0.575648 radiation failures 0.582504 altered fractionation radiation 0.602814 intensity-modulated radiation therapy 0.607841 laryngeal cancers 0.598434 Concurrent radiation therapy 0.626365 advanced larynx cancer 0.579933 radiation field 0.584791 high local control 0.57619 definitive radiation therapy 0.62584 local control 0.651065 external-beam radiation therapy 0.622106 early-stage laryngeal cancer 0.582781 Oncol Biol Phys 0.693462 lymph node involvement 0.5855 particle-beam radiation therapy 0.628769 neck cancer 0.66828 lymph node 0.614894 treatment options 0.588529 local progression-free survival 0.574463 induction chemotherapy 0.734401 Cancer Study Group 0.595423 squamous cell carcinoma 0.619401	CLICK HERE
1755	National Cancer Institute	Html	en	Genetic Testing for Hereditary Cancer Syndromes	A fact sheet about genetic testing for inherited cancer risk. Includes types of tests, who should consider testing, and how to understand test results.	negative test result 0.400337 health care provider 0.502328 genetic mutation 0.416497 family member 0.418619 harmful genetic mutation 0.411753 cancer-predisposing mutation 0.409751 hereditary cancer disorders 0.398762 hereditary cancer syndromes 0.681889 cancer risk condition 0.40678 health care providers 0.394471 hereditary cancer syndrome 0.621674 family members 0.522464 test results 0.569131 major hereditary cancer 0.393709 possible cancer risk 0.406537 certain hereditary cancer 0.433421 cancer types 0.481189 DTC genetic tests 0.42978 person 0.492341 Genetic Information Nondiscrimination 0.390123 genetic tests 0.554486 specific genetic change 0.3911 specific cancer type 0.391368 genetic counselor 0.453074 male breast cancer 0.389105	DTC genetic testing 0.513411 genetic counseling 0.415519 disease-related genetic mutation 0.41195 family medical history 0.39883 positive test result 0.403147 common inherited cancer 0.408932 particular genetic test 0.407943 inherited genetic variants 0.392436 genetic information 0.399804 health care 0.626411 genetic test results 0.557316 genetic change 0.403267 at-home genetic testing 0.430532 prenatal genetic test 0.402782 genetic mutations 0.44962 breast cancer 0.417779 Hereditary breast cancer 0.406679 people 0.398079 health care decisions 0.427407 genetic testing 0.952895 cancer risk 0.555583 hereditary cancer 0.711991 cancer 0.86681 information 0.408541	CLICK HERE
1848	National Cancer Institute	Html	es	Tratamiento del cáncer de piel (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de piel.	Compton CC 0.427006 ángulo nariz-mejilla 0.312075 Cutaneous squamous 0.410175 criocirugía frente 0.310658 skin cancers 0.337834 señalización tipo erizo 0.316126 basal-cell carcinoma 0.31436 American Cancer Society 0.31065 Casciato DA 0.3104 7th ed 0.425796 Dermatol Surg Oncol 0.322688 TFD frente 0.31135 cutaneous carcinomas 0.448478 Mohs surgery is 0.310939 Plast Reconstr Surg 0.318551 carcinomas cutáneos 0.316845 Estados Unidos 0.319384 Natl Cancer Inst 0.311163 human papillomavirus infection 0.320874 CCE invasor 0.312649 Euros frente 0.310849 N2a Metástasis 0.310265 cell carcinomas 0.926899 escisión frente 0.315633 Arch Dermatol 0.342458	Carcinoma apocrino 0.319357 uncomplicated basal cell 0.313087 Invest Dermatol 0.31893 Mohs micrographic surgery 0.311178 micosis fungoide 0.313548 Cancer Staging Manual 0.594205 recidivas locales 0.316877 PDQ Tratamiento 0.321192 New York 0.409746 Day CL Jr 0.315276 clasificación tnm 0.310941 células escamosas cutáneos 0.311636 Dermatol Surg 0.324225 Byrd DR 0.419056 T2b Tumor 0.314992 Karagas MR 0.311264 basal cell carcinomas 0.750035 American Joint Committee 0.344157 párpadoa aReproducción 0.326393 tumor fotosensibilizadores 0.313881 Tis Carcinoma 0.334823 Carcinoma arising 0.318249 AJCC Cancer Staging 0.604512 Edge SB 0.427178	CLICK HERE
1878	National Cancer Institute	Html	es	Tratamiento del cáncer de seno (mama) masculino (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de seno (mama) masculino.	Giordano SH 0.546628 Italian Oncology Group 0.503266 aromatase inhibitors 0.504835 Sin embargo 0.505052 accessed october 0.502081 American Cancer Society 0.521913 sumario tratamiento 0.50893 PALB2 mutations 0.502161 Terapia sistémica preoperatoria 0.504717 Instituto Nacional 0.507139 Vlamis V 0.505558 male breast 0.773618 DeVita VT Jr 0.502939 Wong GY 0.505822 population-based study 0.506079 carcinoma lobulillar 0.502812 hereditary male breast 0.514858 estadificación tnm 0.502579 Buzdar AU 0.511225 breast carcinoma 0.529746 German Breast Group 0.523976 Adjuvant therapy with 0.503518 male breast carcinoma 0.523697 Cancer Facts 0.511201 parientes mujeres 0.50281	tumores pten 0.506695 Cancer Res Treat 0.581998 National Cancer Institute 0.509524 or without gonadotropin-releasing 0.502999 PDQ Tratamiento 0.571327 versus ia 0.508803 Hortobagyi GN 0.519998 Intern Med 0.505973 cancer susceptibility 0.510328 cases from 0.502419 metastatic breast 0.510618 Clin Oncol 0.505305 IA vs 0.504284 Physician Data Query 0.502682 breast cancer 0.966614 estadios tnm 0.502728 Oncology Group Phase 0.503374 Aromatase inhibitors with 0.503642 PDQ Sofocos 0.507587 Current management 0.505493 Oncology Group 0.504752 Borgen PI 0.505535 Hormonal treatment 0.502423 Breast Cancer Res 0.608904	CLICK HERE
1896	National Cancer Institute	Html	es	Tratamiento del cáncer de páncreas (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de páncreas.	estadio lV 0.425648 pequeñas incisiones 0.367032 aguja fina 0.488715 siguientes procedimientos 0.412593 Estadio IA 0.426998 estadio iv 0.507764 siguientes aspectos 0.382876 Ecografía abdominal 0.386812 estadio ii 0.546166 células endocrinas 0.43128 causa ictericia 0.369929 estadios ia 0.357173 siguientes tipos 0.356896 Estadio IIA 0.42546 rayos x 0.367548 enlace drugs approved 0.5669 melanoma familiar atípico 0.436475 ondas sonoras 0.371814 cercanos.ampliar cáncer 0.946814 tumores neuroendocrinos 0.380539 National Cancer Institute 0.355543 estadio lB 0.430806 tejidos cercanos.ampliar cáncer 0.74829	endocrina múltiple tipo 0.4367 Instituto Nacional 0.397986 estadios iia 0.360412 PDQ Tratamiento 0.883614 presente sumario 0.428926 oculto detrás 0.371225 antecedentes familiares 0.366146 Colangiopancreatografía retrógrada 0.374947 Elabora hormonas 0.377934 estadio llA 0.424706 explorador tep 0.376314 Pancreatectomía distal 0.35778 Physician Data Query 0.499092 Pancreatic Cancer 0.442415 enzimas pancreáticas 0.350126 estadio iii 0.513007 Cirugía paliativa 0.414657 antígeno carcinoembrionario 0.380177 von hippel-lindau 0.376964 ovario hereditario 0.376013 linfáticos cercanos.ampliar cáncer 0.783386 siguientes pruebas 0.38409	CLICK HERE
1904	National Cancer Institute	Html	es	Tratamiento del cáncer epitelial de ovario, de trompa de Falopio y primario de peritoneo (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer epitelial de ovario, de trompa de Falopio y primario de peritoneo.	siguientes procedimientos 0.423688 quimioterapia ip 0.416839 estadios ii 0.409427 siguientes aspectos 0.416771 causa hinchazón 0.412974 Ecografía abdominal 0.413715 rayos x 0.41264 estadio ic 0.511392 estadio ivb 0.503452 estadio ib 0.512383 estadio ia 0.511445 enlace drugs approved 0.449365 Fallopian Tube 0.428306 ondas sonoras 0.413458 estadio iva 0.501667 National Cancer Institute 0.410523 Primary Peritoneal Cancer 0.449696 siguientes riesgos 0.40878 realidad células 0.424697 siguientes tratamientos 0.411661 Instituto Nacional 0.43725 estadio iiia 0.506125	PDQ Tratamiento 0.420853 estadio iiic 0.505194 ganglios linfáticos detrás 0.603433 estadio iiib 0.505868 estadio iia 0.510869 estadio iib 0.511005 Physician Data Query 0.437199 or primary peritoneal 0.450381 estadio iii 0.551718 peritoneo causa efectos 0.460442 siguientes situaciones 0.416252 cuello uterino 0.944087 ovario.ampliar anatomía 0.415019 PDQ Prevención 0.426006 histerectomía laparoscópica total.Ampliar 0.422039 siguientes enlaces 0.409849 ecografía transvaginal.Ampliar 0.413879 histerectomía abdominal 0.414317 genes brca1 0.412481 siguientes sumarios 0.425477 siguientes pruebas 0.420302	CLICK HERE
1969	National Cancer Institute	Html	es	Tratamiento del sarcoma de tejido blando en adultos (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del sarcoma de tejido blando en adultos.	estadio lV 0.482165 siguientes procedimientos 0.954883 estadio iv 0.615433 siguientes elementos 0.511302 Neurofibromatosis tipo 0.50222 von recklinghausen 0.491269 estadios ia 0.468147 vía oral 0.457153 estadio il 0.488391 rayos x 0.474452 único tratamiento 0.566108 estadio ib 0.532006 menor cantidad 0.562912 estadio ia 0.530637 carcinoma nevoide 0.493219 National Cancer Institute 0.451467 siguientes riesgos 0.443955 Instituto Nacional 0.590522	PDQ Tratamiento 0.505529 alta potencia 0.472015 estadio iia 0.534137 presente sección 0.449331 tumor haces estrechos 0.590695 Drugs Approved 0.457515 partes distantes 0.468081 Physician Data Query 0.588152 Soft Tissue Sarcoma 0.634121 radioterapia externa causa 0.549798 adultos causa efectos 0.535671 área enteras 0.486295 siguientes enlaces 0.454055 siguientes pruebas 0.644136 siguientes sumarios 0.574908 siguientes estadios 0.500903 siguientes trastornos 0.524918	CLICK HERE
15801	National Cancer Institute	Html	null	Recommendations of the Blue Ribbon Panel	Blue Ribbon Panel Report supporting materials include detailed reports from the BRP's seven working groups and a summary report on the public idea submission site.			CLICK HERE
17186	National Cancer Institute	Html	en	TMIST (Tomosynthesis Mammographic Imaging Screening Trial)	TMIST is a randomized breast screening trial that compares two Food and Drug Administration (FDA)-approved types of digital mammography, standard digital mammography (2-D) with a newer technology called tomosynthesis mammography (3-D).	routine screening mammogram 0.506393 entire study group 0.421549 tomosynthesis mammography 0.449515 health plans 0.41281 3-D mammography 0.660743 trial 0.465454 breast cancer status 0.514295 standard digital mammography 0.512193 3-D mammogram 0.462356 women ages 0.504522 following factors 0.42666 breast biopsies 0.439927 fewer false-positive test 0.416422 researchers 0.394009 2-D screening mammograms 0.502737 mammography clinics 0.435449 aggressive breast cancers 0.493477 ECOG-ACRIN Cancer Research 0.42875 2-D mammography 0.505053 3-D mammograms 0.447984 hormone replacement therapy 0.765582 randomized breast 0.472367 personal risk factors 0.42803 primary care doctors 0.417168 women 0.662197	risk changes 0.412147 fewer harder-to-treat cancers 0.422139 study 0.460399 best ways 0.450667 mammograms 0.529145 age group 0.430585 certain groups 0.456471 breast cancers 0.534289 dense breasts 0.527755 complete cost 0.412269 premenopausal women 0.386263 routine mammogram 0.443785 mammogram 0.569066 3-D mammography machines 0.510266 3-D mammography images 0.549905 breast cancer screening 0.609852 newly diagnosed breast 0.491574 nearby lymph node 0.415404 breast cancer 0.940336 trial record 0.381013 tissue samples 0.430822 genetic changes 0.428717 Women’s health 0.38389 family history 0.510755	CLICK HERE